Allison Betof
· MD, PhD, FASCO Associate Professor of Medicine (Oncology)Stanford University · Medical Oncology
Active 2010–2024
About
Allison Betof, MD, PhD, FASCO, is an Associate Professor of Medicine (Oncology) at Stanford University School of Medicine. She serves as the Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and is a Mark & Mary Stevens Endowed Scholar in Melanoma. Dr. Betof completed her MD and PhD at Duke University, her Internal Medicine residency at Massachusetts General Hospital (Harvard University), and her Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Her laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is recognized internationally for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for melanoma and other solid tumors. Her work has been supported by funding and awards from organizations such as the American Society of Clinical Oncology, the National Institutes of Health, the Melanoma Research Alliance, and the Melanoma Research Foundation.
Research signals
Five dimensions sourced from public faculty / publication signals. Sign in to compare against your own profile and see your match score.
Labs
Stanford Melanoma ProgramPI
Awards & honors
- Innovation of Care Award, Stanford Healthcare (2025)
Similar researchers at Stanford University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Allison Betof
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup